Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Dec 23, 2009

30339_dirs_2009-12-23_d7395a82-acec-4cd2-9ac7-f6bf7be03840.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-12-22

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-12-22 Common Stock G 2500 Disposed 228543.6513 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1123.08 Indirect
Common Stock 27987.4109 Indirect